ClinicalTrials.Veeva

Menu

Rasch-analysis of Clinical Severity in FSHD (ROC-FSHD)

University of Kansas logo

University of Kansas

Status

Completed

Conditions

Facioscapulohumeral Muscular Dystrophy

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT02766985
UL1TR000001 (U.S. NIH Grant/Contract)
STUDY00003640

Details and patient eligibility

About

The purpose of this study is to make a standardized and scalable Rasch-built clinical severity scale to help in finding genetic and environmental modifiers of disease in Facioscapulohumeral muscular dystrophy (FSHD).

Enrollment

44 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Genetic confirmation of FSHD (either FSHD-1 or FSHD-2)

Exclusion criteria

  • Do not understand English
  • Unable to provide informed consent

Trial design

44 participants in 1 patient group

FSHD
Description:
Participants with FSHD-1 or FSHD-2. No intervention is given to participants. Participants will undergo series of tests and procedures in order to make a standardized and scalable Rasch-built clinical severity scale.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems